What is Medicinal Mindfulness?
Medicinal Mindfulness operates as a specialized psychedelic therapy center, positioning itself at the intersection of clinical mental health and holistic wellness. The organization provides a comprehensive suite of services, including cannabis-assisted and ketamine-assisted therapy, alongside psilocybin mushroom support services. By adhering to the regulatory framework of the Natural Medicine Health Act, the company distinguishes itself through a mindfulness-based therapeutic model. Its market position is defined by a commitment to providing transformative experiences for individuals navigating complex emotional and psychological challenges, effectively bridging the gap between traditional psychiatric care and emerging alternative therapeutic modalities.
How much funding has Medicinal Mindfulness raised?
Medicinal Mindfulness has raised a total of $10K across 1 funding round:
Debt
$10K
Debt (2021): $10K with participation from PPP
Key Investors in Medicinal Mindfulness
PPP
Public-Private Partnership
What's next for Medicinal Mindfulness?
With the recent influx of capital, Medicinal Mindfulness is well-positioned to accelerate its strategic roadmap. The firm is expected to prioritize the expansion of its physical infrastructure and the refinement of its clinical protocols to meet increasing demand for alternative mental health solutions. Future growth will likely focus on deepening regulatory compliance, enhancing practitioner training programs, and potentially scaling its service delivery model to new geographic markets. As the regulatory environment for psychedelic-assisted therapy continues to evolve, the company's ability to maintain its mindfulness-centric approach while scaling operations will be a key determinant of its long-term market leadership and sustained financial performance.
See full Medicinal Mindfulness company page
